Atlas Trials

Adjustment of Aminoglycoside Dosing Based on Peak Serum Concentration and Bacterial Minimal Inhibitory Concentration

Clinical trial NCT05618457 · UNKNOWN

Trial details

NCT number
NCT05618457
Sponsor
Hadassah Medical Organization
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Aminoglycoside Dosing Based on PK/PD Characteristics
Start date
2021-12-01
Primary completion
2025-12-31
Enrollment
151

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.